Results 241 to 250 of about 227,142 (341)
Abstract Exposure levels without appreciable human health risk may be determined by dividing a point of departure on a dose–response curve (e.g., benchmark dose) by a composite adjustment factor (AF). An “effect severity” AF (ESAF) is employed in some regulatory contexts.
Barbara L. Parsons+17 more
wiley +1 more source
Genome editing for sustainable agriculture in Peru: advances, potential applications and regulation. [PDF]
Mestanza M+4 more
europepmc +1 more source
Efficient Conditional Transgene Expression in Hepatitis C Virus cDNA Transgenic Mice Mediated by the Cre/loxP System [PDF]
Takaji Wakita+9 more
openalex +1 more source
Overexpression of TSG101 causes the development of adenosquamous mammary carcinoma. [PDF]
Dennaoui R+13 more
europepmc +1 more source
Efficient Liver-specific Deletion of a Floxed Human Angiotensinogen Transgene by Adenoviral Delivery of Cre Recombinasein Vivo [PDF]
David E. Stec+4 more
openalex +1 more source
Diverse Subpopulations of Reactive Astrocytes Following Chronic Toxoplasma Infection
Toxoplasma infection results in distinct astrocyte subpopulations. Chronically labeled reactive astrocytes appear transcriptionally plastic and can regain acute inflammatory responding and naive homeostatic astrocytic gene patterns in the presence of ongoing neuroinflammation.
Zoe A. Figueroa+7 more
wiley +1 more source
Development and Characterization of the NISTCHO Reference Cell Line. [PDF]
Dahodwala H+19 more
europepmc +1 more source